⌘K

Login Start Free

Home/Filings/4/0001593968-24-000838

4//SEC Filing

Humer Franz B 4

Accession 0001593968-24-000838

CIK 0001737287other

View on SEC.gov Company Profile

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 5:30 PM ET

Size

6.6 KB

Accession

0001593968-24-000838

Insider Transaction Report

Form 4

Period: 2024-06-05

Allogene Therapeutics, Inc.ALLO

Director

Transactions

Award
Common Stock
2024-06-05+61,475→ 316,728 total
Award
Stock Option (Right to buy)
2024-06-05+95,541→ 95,541 total
Exercise: $2.44Exp: 2034-06-05→ Common Stock (95,541 underlying)

Footnotes (1)

[F1]Vesting in 12 equal monthly installments

Documents

1 file

4
primary_01.xmlPrimary
PRIMARY DOCUMENT

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1

filerCIK 0001548072

Filing Metadata

Form type: 4
Filed: Jun 6, 8:00 PM ET
Accepted: Jun 7, 5:30 PM ET
Size: 6.6 KB

View on SEC.gov